###begin article-title 0
###xml 20 25 20 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNJ6</italic>
###xml 27 32 27 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GIRK2</italic>
Association between KCNJ6 (GIRK2) Gene Polymorphisms and Postoperative Analgesic Requirements after Major Abdominal Surgery
###end article-title 0
###begin p 1
Conceived and designed the experiments: DN SK NS IS MH KI. Performed the experiments: DN JH. Analyzed the data: DN YO. Contributed reagents/materials/analysis tools: DN YO WH JH. Wrote the paper: DN MH KI. Collection of DNA: YO KI. Collection of clinical data and DNA: MN RK YS MT MH.
###end p 1
###begin p 2
###xml 533 538 533 538 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNJ6</italic>
###xml 1169 1174 1161 1166 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNJ6</italic>
###xml 1445 1450 1437 1442 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNJ6</italic>
###xml 1345 1350 <span type="species:ncbi:9606">human</span>
Opioids are commonly used as effective analgesics for the treatment of acute and chronic pain. However, considerable individual differences have been widely observed in sensitivity to opioid analgesics. We focused on a G-protein-activated inwardly rectifying potassium (GIRK) channel subunit, GIRK2, that is an important molecule in opioid transmission. In our initial polymorphism search, a total of nine single-nucleotide polymorphisms (SNPs) were identified in the whole exon, 5'-flanking, and exon-intron boundary regions of the KCNJ6 gene encoding GIRK2. Among them, G-1250A and A1032G were selected as representative SNPs for further association studies. In an association study of 129 subjects who underwent major open abdominal surgery, the A/A genotype in the A1032G SNP and -1250G/1032A haplotype were significantly associated with increased postoperative analgesic requirements compared with other genotypes and haplotypes. The total dose (mean+/-SEM) of rescue analgesics converted to equivalent oral morphine doses was 20.45+/-9.27 mg, 10.84+/-2.24 mg, and 13.07+/-2.39 mg for the A/A, A/G, and G/G genotypes in the A1032G SNP, respectively. Additionally, KCNJ6 gene expression levels in the 1032A/A subjects were significantly decreased compared with the 1032A/G and 1032G/G subjects in a real-time quantitative PCR analysis using human brain tissues, suggesting that the 1032A/A subjects required more analgesics because of lower KCNJ6 gene expression levels and consequently insufficient analgesic effects. The results indicate that the A1032G SNP and G-1250A/A1032G haplotype could serve as markers that predict increased analgesic requirements. Our findings will provide valuable information for achieving satisfactory pain control and open new avenues for personalized pain treatment.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 192 195 192 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007060-Ikeda1">[1]</xref>
###xml 353 356 353 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007060-Coulbault1">[2]</xref>
Opioids are commonly used as effective analgesics for the treatment of acute and chronic pain. However, sensitivity to opioid analgesics is well known to vary widely among individual subjects [1]. Individual differences can be attributed to both genetic and environmental factors, although the relative influence of each of these factors can be diverse [2]. Genetic variations in opioid-related genes involved in opioid pharmacokinetics and pharmacodynamics might lead to individual differences in phenotypes related to pharmacological actions of opioid analgesics.
###end p 4
###begin p 5
###xml 331 334 331 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007060-Ikeda2">[3]</xref>
Numerous molecules are involved in the pharmacological effects of opioids. Opioid ligands bind to opioid receptors, and the signal is transmitted to a variety of effectors (e.g., adenylate cyclase, calcium ion channels, and G-protein-activated inwardly rectifying potassium [GIRK] channels), thereby resulting in analgesic effects [3]. The genes encoding these molecules are candidates for researching the relationships between genetic variations and individual differences in phenotypes related to opioid actions.
###end p 5
###begin p 6
###xml 228 231 228 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007060-Ikeda2">[3]</xref>
###xml 330 335 330 335 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kcnj9</italic>
###xml 343 348 343 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Girk3</italic>
###xml 442 445 442 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007060-Smith1">[4]</xref>
###xml 590 593 590 593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007060-Kobayashi1">[5]</xref>
###xml 660 663 660 663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007060-Marker1">[6]</xref>
###xml 677 680 677 680 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007060-Marker2">[7]</xref>
###xml 682 685 682 685 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007060-Marker3">[8]</xref>
###xml 756 759 756 759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007060-Jelacic1">[9]</xref>
###xml 760 764 760 764 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007060-Wickman1">[11]</xref>
###xml 829 832 829 832 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i/o</sub>
###xml 887 891 887 891 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007060-Ikeda3">[12]</xref>
###xml 1101 1104 1101 1104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007060-Marker1">[6]</xref>
###xml 1106 1109 1106 1109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007060-Marker2">[7]</xref>
###xml 1111 1115 1111 1115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007060-Blednov1">[13]</xref>
###xml 1116 1120 1116 1120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007060-Mitrovic1">[15]</xref>
###xml 337 342 <span type="species:ncbi:10090">mouse</span>
###xml 924 928 <span type="species:ncbi:10090">mice</span>
Among opioid-related genes, GIRK channels are attractive targets for the investigation of the relationship between genetic variations and sensitivity to opioid analgesics because they play a key role in opioid-induced analgesia [3]. Additionally, recent quantitative trait locus analysis and computational mapping have identified Kcnj9 (mouse Girk3) as a candidate gene affecting variability in the analgesia induced by multiple drug classes [4]. GIRK channels are members of the inwardly rectifying potassium channel family, and four subtypes (GIRK1-GIRK4) have been identified in mammals [5]. GIRK channels are expressed in many tissues, including the heart [6], spinal cord [7], [8], and various regions in the brain with different subunit compositions [9]-[11]. GIRK channel activation is triggered by activation of several Gi/o protein-coupled receptors, including opioid receptors [12]. Several studies using knockout mice have shown that opioid-induced GIRK channel activation co-expressed with opioid receptors leads to inhibition of nociceptive transmission and thus opioid-induced analgesia [6], [7], [13]-[15].
###end p 6
###begin p 7
###xml 222 226 222 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007060-Sakura1">[16]</xref>
###xml 227 231 227 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007060-Yasuda1">[18]</xref>
###xml 332 337 332 337 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNJ6</italic>
###xml 476 479 476 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007060-Marker1">[6]</xref>
###xml 481 484 481 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007060-Marker2">[7]</xref>
###xml 486 490 486 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007060-Blednov1">[13]</xref>
###xml 491 495 491 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007060-Mitrovic1">[15]</xref>
###xml 568 573 568 573 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNJ6</italic>
###xml 135 141 <span type="species:ncbi:9606">humans</span>
###xml 184 189 <span type="species:ncbi:9606">human</span>
To date, however, few studies have examined the relationship between genetic variations in GIRK channels and phenotypic differences in humans, although several studies have identified human GIRK channel gene polymorphisms [16]-[18]. Therefore, the present study focused on GIRK channel gene polymorphisms, particularly those of the KCNJ6 gene encoding GIRK2 because it has been investigated more extensively than the other subtypes with regard to its involvement in analgesia [6], [7], [13]-[15]. We sought to reveal the relationship between genetic variations in the KCNJ6 gene and individual differences in opioid analgesic sensitivity.
###end p 7
###begin title 8
Methods
###end title 8
###begin title 9
Ethics Statement
###end title 9
###begin p 10
The study protocol was approved by the Institutional Review Boards at the Institute of Medical Science, The University of Tokyo (Tokyo, Japan), Toho University Sakura Medical Center (Sakura, Japan), and the Tokyo Institute of Psychiatry (Tokyo, Japan). All subjects provided informed, written consent for the genetics studies.
###end p 10
###begin title 11
Subjects
###end title 11
###begin p 12
###xml 37 42 37 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNJ6</italic>
###xml 270 282 <span type="species:ncbi:9606">participants</span>
Subjects for the resequencing of the KCNJ6 gene were recruited from the Kanto area in Japan. A total of 48 unrelated healthy subjects were used in the study so that polymorphisms with allele frequency more than approximately 1% could be detected. The oral mucosa of the participants was collected for gene analysis.
###end p 12
###begin p 13
###xml 52 60 <span type="species:ncbi:9606">patients</span>
The subjects used in the association study were 129 patients who underwent major open abdominal surgery, mostly gastrectomy for gastric cancer and colectomy for colorectal cancer, under combined general and epidural anesthesia at Research Hospital, Institute of Medical Science, The University of Tokyo, or at Toho University Sakura Medical Center. Peripheral blood or oral mucosa samples were collected from these subjects for gene analysis.
###end p 13
###begin p 14
###xml 11 16 11 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNJ6</italic>
###xml 56 61 <span type="species:ncbi:9606">human</span>
###xml 89 94 <span type="species:ncbi:9606">human</span>
###xml 147 152 <span type="species:ncbi:9606">human</span>
To examine KCNJ6 gene expression levels, a total of 105 human DNA samples extracted from human occipital cortex and 100 RNA samples extracted from human anterior cingulate cortex of the same specimens were additionally obtained from the Stanley Medical Research Institute (Bethesda, MD) as samples independent of that in the association study (SMRI samples).
###end p 14
###begin title 15
Clinical data
###end title 15
###begin p 16
###xml 321 328 <span type="species:ncbi:9606">patient</span>
###xml 976 984 <span type="species:ncbi:9606">patients</span>
Postoperative pain was managed primarily with continuous epidural analgesia with fentanyl or morphine. Fentanyl or morphine was diluted with 0.25% bupivacaine in a total volume of 100 ml and infused at a constant rate of 2 ml/h through a catheter placed in the lower thoracic or upper lumbar epidural space. Whenever the patient complained of significant postoperative pain despite continuous epidural analgesic, appropriate doses of opioids, including morphine, buprenorphine, pentazocine, and pethidine, and/or nonsteroidal anti-inflammatory drugs (NSAIDs), including diclofenac and flurbiprofen, were administered as rescue analgesics at the discretion of surgeons. The clinical data sampled included age, gender, body height, body weight, postoperative diagnosis, type of operation, duration of operation, and doses of rescue analgesics (opioids and/or NSAIDs) administered during the first 24 h postoperative period, for which analgesic therapy would be required in most patients. The study subjects were also asked to rate their pain intensity at rest during the first 24 h postoperative period using a 5-point verbal numerical rating scale (NRS; 0 = no pain, 1 = mild pain, 2 = moderate pain, 3 = severe pain, 4 = extremely severe pain).
###end p 16
###begin p 17
###xml 280 284 280 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007060-Hayashida1">[19]</xref>
###xml 402 409 402 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007060-t001">Table 1</xref>
###xml 715 723 <span type="species:ncbi:9606">patients</span>
To allow intersubject comparisons of rescue analgesic doses required during the first 24 h postoperative period, doses of opioids and NSAIDs administered as rescue analgesics during this period were converted to the equivalent dose of oral morphine according to a previous report [19]. The conversion factor used for the different analgesics to derive equivalent doses of oral morphine is presented in Table 1. The frequency of rescue analgesic administration was determined as the frequency of use of rescue analgesics during the first 24 h postoperative period. The total dose of rescue analgesics administered was calculated as the sum of oral morphine-equivalent doses of all opioids and NSAIDs administered to patients as rescue analgesics during the same period.
###end p 17
###begin title 18
Estimated systemic dose equipotent to 90 mg oral morphine (mg).
###end title 18
###begin title 19
Resequencing KCNJ6 and SNP selection for the association study
###end title 19
###begin p 20
###xml 47 52 47 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNJ6</italic>
###xml 189 194 187 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNJ6</italic>
###xml 196 201 194 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GIRK2</italic>
###xml 623 631 621 629 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007060-g001">Figure 1</xref>
###xml 682 689 680 687 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007060-t002">Table 2</xref>
###xml 183 188 <span type="species:ncbi:9606">human</span>
To comprehensively screen polymorphisms in the KCNJ6 gene, resequencing was performed using an ABI PRISM(R) 3100 Genetic Analyzer (Life Technologies Japan Ltd., Tokyo, Japan) for the human KCNJ6 (GIRK2) gene regions (mapped to 21q22.13-q22.2) and 5'-flanking region based on the nucleotide sequences of the GenBank database (accession number: NT_011512). The screened regions contained all consensus sequences of exon regions, exon-intron boundary regions (approximately 30 bp), and putative promoter regions (approximately 1.8 kbp) for the gene. The total length of the screened regions approximately amounted to 4.5 kbp (Figure 1). All primers used for the screening are shown in Table 2.
###end p 20
###begin title 21
###xml 74 79 74 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNJ6</italic>
The position of the SNPs identified in the polymorphism screening for the KCNJ6 gene.
###end title 21
###begin p 22
###xml 271 276 271 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNJ6</italic>
###xml 481 483 481 483 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D'</italic>
###xml 490 491 490 491 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 489 491 489 491 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r<sup>2</sup></italic>
The filled box and striped box represent the coding region and untranslated region, respectively. The horizontal arrows indicate the screened regions. The numbers above the boxes and in the exonic SNPs are relative positions from the transcription start site (+1) in the KCNJ6 mRNA, and the number "75167" in the IVS1C75167T SNP is the relative position from the intron 1 start site in the genomic DNA. The underlined SNPs show absolute linkage disequilibrium between one another (D' = 1, r2 = 1).
###end p 22
###begin title 23
Primers used in the analyses.
###end title 23
###begin p 24
Forward/Reverse, sense/antisense strand sequences of the gene, respectively; Primer No., the ID number of the primer described in the paper.
###end p 24
###begin p 25
###xml 154 158 154 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007060-Carlson1">[20]</xref>
###xml 159 163 159 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007060-deBakker1">[22]</xref>
###xml 325 329 325 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007060-Barrett1">[23]</xref>
###xml 397 399 397 399 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D&#8242;</italic>
###xml 405 406 405 406 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 404 406 404 406 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r<sup>2</sup></italic>
###xml 587 591 587 591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007060-Gabriel1">[24]</xref>
###xml 647 649 647 649 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D&#8242;</italic>
###xml 868 872 868 872 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007060-deBakker1">[22]</xref>
Single-nucleotide polymorphisms (SNPs) for the association studies were selected based on several factors, including recently advanced tagging strategies [20]-[22]. To identify relationships between the SNPs identified in the polymorphism screening, linkage disequilibrium (LD) analysis was performed using Haploview v. 3.32 [23]. For estimation of LD strength between the SNPs, the commonly used D' and r2 values were pairwise calculated using the genotype dataset of each SNP. LD blocks were defined among the SNPs showing "strong LD," based on the default algorithm of Gabriel et al. [24], in which the upper and lower 95% confidence limits on D' for strong LD were set at 0.98 and 0.7, respectively. Tag SNPs in the LD block were consequently determined by the software package Tagger, which is incorporated in Haploview and has been detailed in a previous report [22].
###end p 25
###begin title 26
Genotyping
###end title 26
###begin p 27
Total genomic DNA was extracted from peripheral blood or oral mucosa samples by standard procedures.
###end p 27
###begin p 28
###xml 15 20 15 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNJ6</italic>
###xml 279 286 279 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007060-t002">Table 2</xref>
###xml 992 993 926 927 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
For genotyping KCNJ6 G-1250A, the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method and direct sequencing were adopted. To perform PCR-RFLP, the restriction enzyme BsmI (Toyobo Co., Ltd., Tokyo, Japan) and two primers of P5F and P6R were used (Table 2). First, PCR was performed in a final volume of 10 microl containing 5xGoTaqtrade mark reaction buffer (7.5 mM magnesium), 0.16 mM dioxyribonucleoside triphosphate (dNTP), 0.4 microM of each primer, 0.5 U GoTaqtrade mark DNA polymerase (Promega K.K. Japan, Tokyo, Japan), and 5-50 ng extracted genomic DNA as the template. The PCR program was the following: 95degreesC for 2 min, followed by 35 cycles of 95degreesC for 30 s, 60degreesC for 30 s, and 72degreesC for 1 min, with a final extension at 72degreesC for 8 min. The amplified DNA fragments were digested by the restriction enzyme at 65degreesC in a total of 15 microl reaction solution containing 10xM buffer (100 mM Tris-HCl, pH 7.5, 100 mM MgCl2, 500 mM NaCl, 10 mM dithiothreitol), 0.3 U BsmI, and 3.5 microl PCR product as the substrate. The digestion products were analyzed by electrophoresis using 1-2% agarose gel and ethidium bromide staining for visualization under ultraviolet illumination. The appearance of only the 601 bp DNA fragment corresponded to the A/A genotype of the loaded sample. The appearance of both the 233 bp and 370 bp fragments corresponded to the G/G genotype, and the appearance of all three 601 bp, 233 bp, and 370 bp DNA fragments corresponded to the G/A genotype. The failure rate of the RFLP genotyping assays was 1.667%.
###end p 28
###begin p 29
###xml 15 20 15 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNJ6</italic>
###xml 317 324 317 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007060-t002">Table 2</xref>
###xml 1000 1001 934 935 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1903 1908 1820 1825 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNJ6</italic>
###xml 2176 2177 2081 2082 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
For genotyping KCNJ6 A1032G, the PCR-RFLP method, TaqMan allelic discrimination assay (Life Technologies Japan Ltd.) and direct sequencing were adopted. To perform PCR-RFLP, the restriction enzyme BspEI (New England Biolabs, Inc., Ipswich, MA) was used. The forward primer P23F and the reverse primer P24R were used (Table 2). First, PCR was performed in a final volume of 10 microl containing 5xGoTaqtrade mark reaction buffer (7.5 mM magnesium), 0.16 mM dNTP, 0.4 microM of each primer, 0.5 U GoTaqtrade mark DNA polymerase (Promega K.K. Japan, Tokyo, Japan), and 5-50 ng extracted genomic DNA as the template. The PCR program was the following: 95degreesC for 2 min, followed by 35-40 cycles of 95degreesC for 30 s, 50degreesC for 30 s, and 72degreesC for 1 min, with a final extension at 72degreesC for 8 min. The amplified DNA fragments were digested by the restriction enzyme at 37degreesC in a total of 10 microl reaction solution containing 10xNEBuffer 3 (500 mM Tris-HCl, pH 7.9, 100 mM MgCl2, 1000 mM NaCl, 10 mM dithiothreitol), 0.5 U BspEI, and 5 microl PCR product as the substrate. The digestion products were analyzed by electrophoresis using 1-2% agarose gel and ethidium bromide staining for visualization under ultraviolet illumination. A 65 bp digested DNA fragment is not easily distinguishable; therefore, the appearance of 395 bp, 332 bp, and both 395 bp and 332 bp DNA fragments corresponded to the A/A, G/G, and A/G genotypes, respectively, of the loaded sample. The failure rate of the RFLP genotyping assays was 3.571%. To perform the TaqMan allelic discrimination assay with a LightCycler 480 (Roche Diagnostics K.K., Tokyo, Japan), TaqMan(R) SNP Genotyping Assays (Life Technologies Japan Ltd.) containing sequence-specific forward and reverse primers to amplify the polymorphic sequence and two probes labeled with VIC(R) and FAMtrade mark dye to detect both alleles of the KCNJ6 A1032G (Assay ID: C_15868122_10) were used. Real-time PCR was performed in a final volume of 10 microl containing 2xLightCycler(R) 480 Probes Master (Roche Diagnostics K.K.), 40xTaqMan(R) Gene Expression Assays, 5 ng genomic DNA as the template, and up to 10 microl H2O equipped with 2xLightCycler(R) 480 Probes Master. The thermal condition was the following: 95degreesC for 10 min, followed by 45 cycles of 95degreesC for 10 s and 60degreesC for 60 s, with a final cooling at 50degreesC for 30 s. Afterward, endpoint fluorescence was measured for each sample well, and the A/A, A/G, and G/G genotypes were determined based on the presence or absence of each type of fluorescence.
###end p 29
###begin p 30
###xml 48 53 48 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNJ6</italic>
###xml 66 71 66 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNJ6</italic>
For samples that were difficult to genotype for KCNJ6 G-1250A and KCNJ6 A1032G using the PCR-RFLP method, direct sequencing was adopted to determine the sequence with both forward and reverse primers enclosing the SNP sites.
###end p 30
###begin title 31
Real-time quantitative PCR (qPCR)
###end title 31
###begin p 32
The SMRI RNA samples were treated with DNase I using RNase-Free DNase Set (QIAGEN K.K., Tokyo, Japan) at room temperature (20-25degreesC) for 10 min, and then clean-up was performed using RNeasy(R) MinElute(R) Cleanup Kit (QIAGEN). First-strand cDNA for use in real-time qPCR was synthesized with the SuperScriptIII First-Strand synthesis system for qRT-PCR (Life Technologies Japan Ltd.) with 100 ng purified total RNA according to the manufacturer's protocol.
###end p 32
###begin p 33
###xml 194 199 192 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNJ6</italic>
###xml 262 266 260 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACTB</italic>
###xml 532 533 507 508 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 883 888 808 813 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNJ6</italic>
###xml 924 928 849 853 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACTB</italic>
###xml 964 969 889 894 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNJ6</italic>
To perform real-time qPCR utilizing a LightCycler 480 (Roche Diagnostics K.K.), TaqMan(R) Gene Expression Assays (Life Technologies Japan Ltd.) were used as a probe/primer set specified for the KCNJ6 gene (Assay ID: Hs01040524_m1) and a probe/primer set for the ACTB gene, a house-keeping gene, encoding beta-actin (Assay ID: Hs99999903_m1). PCR was performed in a final volume of 20 microl containing 2xLightCycler(R) 480 Probes Master, 1 microl TaqMan(R) Gene Expression Assay, 1 microl cDNA as the template, and up to 20 microl H2O equipped with 2xLightCycler(R) 480 Probes Master. The PCR program was the following: 95degreesC for 10 min, 45 cycles of 95degreesC for 10 s and 60degreesC for 30 s, followed by 95degreesC for 10 s, 50degreesC for 30 s, 50-70degreesC (continuously) at a rate 0.06degreesC/s, with a final cooling at 50degreesC for 30 s. The expression level of the KCNJ6 gene was normalized to that of the ACTB gene for each sample, and relative KCNJ6 mRNA expression levels between all samples were compared by setting the lowest expression level among all SMRI samples as 1. Experiments were performed in duplicate (separate experiments) for each sample, and averaged values were calculated for normalized expression levels.
###end p 33
###begin title 34
Predictions of mRNA secondary structure
###end title 34
###begin p 35
###xml 76 81 76 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNJ6</italic>
###xml 155 159 155 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007060-Zuker1">[25]</xref>
###xml 165 170 165 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNJ6</italic>
To discuss in depth mRNA sequence and function, the secondary structure for KCNJ6 mRNA was predicted using Mfold web server (v. 3.2) with default settings [25]. The KCNJ6 mRNA position 982-1082 was used to predict the local structure of the mRNA based on the nucleotide sequences of the GenBank database (accession number: NM_002240.2).
###end p 35
###begin title 36
Statistical analysis
###end title 36
###begin p 37
###xml 7 8 5 6 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 4 8 4 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#967;<sup>2</sup></italic>
###xml 713 721 711 719 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">post hoc</italic>
###xml 1134 1135 1132 1133 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 1208 1209 1206 1207 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 1240 1245 1238 1243 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNJ6</italic>
###xml 1453 1457 1451 1455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007060-Faul1">[26]</xref>
###xml 1493 1497 1491 1495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007060-Purcell1">[27]</xref>
###xml 1520 1524 1518 1522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007060-Barrett1">[23]</xref>
###xml 1748 1752 1746 1750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007060-Benjamini1">[28]</xref>
###xml 1822 1823 1820 1821 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 551 559 <span type="species:ncbi:9606">patients</span>
The chi2 test or Fisher exact test was performed for all genotype frequency data using FreeJSTAT 8.2 for Windows (free software by M. Sato, Japan; current version is available at ) or Simple Interactive Statistical Analysis (free software by Quantitative Skills, The Netherlands; current version is available at ) to investigate the deviation of the distributions from those in the theoretical Hardy-Weinberg equilibrium. Analysis of covariance (ANCOVA) was performed to examine the contribution of the SNPs to the subjective pain ratings reported by patients, frequency of 24 h analgesic requirements, and analgesic requirements during the 24 h postoperative period. Bonferroni multiple comparisons were used as post hoc tests. Correction of multiple testing was not performed for the results of the G-1250A and A1032G SNPs in this explorative study. The age, height, and weight of the subjects were incorporated as covariables for the ANCOVA because these three factors were found to be significant covariables in a preliminary analysis and may affect analgesic efficacy of opioids and/or NSAIDs. Pearson's correlation coefficient (r) was calculated to examine the correlation between variables. Student's t-test was performed to compare KCNJ6 expression levels between the A1032G genotype subgroups. For these three analyses, SPSS 12.0J for Windows (SPSS Japan, Inc., Tokyo, Japan) was used. Power analyses were performed using G*Power Version 3.0.5 [26]. gPLINK v. 2.049, PLINK v. 1.01 () [27], and Haploview v. 4.0 [23] were used for haplotype-specific tests, incorporating gender, age, height, and weight of the subjects as covariables, with the false discovery rate set at 0.05 for correction of multiple testing, based on a previous report [28]. In all statistical tests, the criterion for significance was set at P<0.05.
###end p 37
###begin title 38
Results
###end title 38
###begin p 39
###xml 105 110 105 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNJ6</italic>
###xml 211 219 211 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007060-g001">Figure 1</xref>
###xml 285 290 285 290 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNJ6</italic>
###xml 345 352 345 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007060-t003">Table 3</xref>
###xml 607 614 607 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007060-t003">Table 3</xref>
###xml 798 800 798 800 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D'</italic>
###xml 806 807 806 807 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 805 807 805 807 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r<sup>2</sup></italic>
###xml 829 834 829 834 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNJ6</italic>
###xml 856 863 856 863 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007060-t004">Table 4</xref>
###xml 878 880 878 880 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D'</italic>
###xml 887 888 887 888 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 886 888 886 888 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r<sup>2</sup></italic>
###xml 949 956 949 956 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007060-t004">Table 4</xref>
###xml 1134 1141 1134 1141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007060-t003">Table 3</xref>
###xml 1582 1587 1582 1587 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNJ6</italic>
In the first polymorphism search in the whole exon, 5'-flanking, and exon-intron boundary regions of the KCNJ6 gene, a total of nine SNPs were identified in the 5'-flanking region, intron 1, exon 3, and exon 4. Figure 1 illustrates the relative positions of the SNPs identified in the KCNJ6 gene. The characteristics of the SNPs are provided in Table 3, where the minor allele frequencies of the SNPs are also shown. The allele frequencies of the SNPs observed in this study were comparable (less than 0.1 difference) to those annotated in the National Center for Biotechnology Information (NCBI) database (Table 3). SNPs for a further association study were selected, considering the LD structure, minor allele frequencies of the SNPs, and the expected impact on gene function. The results of the D' and r2 calculations for the KCNJ6 gene are provided in Table 4. Absolute LD (D' = 1, r2 = 1) was observed between SNPs G-1250A, T-244C, and C-227T (Table 4), and Haploview also identified G-1250A as a candidate haplotype-tagging SNP in this LD block structure. The minor allele frequencies for these three SNPs were relatively high (Table 3), and G-1250A was selected for the association study. Among the remaining six SNPs, IVS1C75467T and A1032G are relatively common, with minor allele frequencies greater than 0.1, and could be candidates for an association study. Because IVS1C75467T is in the intron region and thus is less likely to affect the mRNA product or protein levels, it was not selected as a candidate SNP. Therefore, G-1250A and A1032G were selected from the nine KCNJ6 SNPs for the association study.
###end p 39
###begin title 40
###xml 50 55 50 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNJ6</italic>
The characteristics of the identified SNPs in the KCNJ6 gene.
###end title 40
###begin p 41
rs ID, reference SNP ID in the NCBI dbSNP database; Sample size, the number of samples used for genotyping each SNP; Reported allele, the allele appearing in the GenBank reference sequence. The numbers in parentheses represent the minor allele frequencies for the Japanese population described in the NCBI dbSNP database. N.A., not available.
###end p 41
###begin title 42
###xml 9 11 9 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D'</italic>
###xml 17 18 17 18 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 16 18 16 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r<sup>2</sup></italic>
###xml 61 66 61 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNJ6</italic>
Pairwise D' and r2 values between the identified SNPs in the KCNJ6 gene.
###end title 42
###begin p 43
###xml 89 91 89 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D'</italic>
###xml 97 98 97 98 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 96 98 96 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r<sup>2</sup></italic>
###xml 159 161 159 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D'</italic>
###xml 219 221 219 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D'</italic>
###xml 235 236 235 236 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 234 236 234 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r<sup>2</sup></italic>
The numbers above and below the hyphens show the results of the pairwise calculations of D' and r2 between the two SNPs, respectively. The values representing D' = 1.000 are underlined. The pairs of values representing D' = 1.000 and r2 = 1.000 are italicized and bold.
###end p 43
###begin p 44
###xml 406 413 406 413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007060-t005">Table 5</xref>
###xml 528 535 528 535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007060-t005">Table 5</xref>
###xml 594 599 594 599 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNJ6</italic>
###xml 663 671 663 671 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007060.s001">Table S1</xref>
###xml 241 248 <span type="species:ncbi:9606">patient</span>
###xml 453 461 <span type="species:ncbi:9606">patients</span>
###xml 506 514 <span type="species:ncbi:9606">patients</span>
The genotype distributions for the two SNPs that were selected were not significantly different from the theoretical Hardy-Weinberg equilibrium values in independent tests of the 48 healthy subjects used in the resequencing procedure or 129 patient subjects used in the association analyses (data not shown). The clinical data of the 129 subjects who were included in the association study are provided in Table 5. Rescue analgesics were required in 59 patients. Doses of rescue analgesics administered to patients are shown in Table 5. More detailed clinical data stratified by each genotype (KCNJ6 G-1250A and A1032G) are presented as Supporting Information in Table S1.
###end p 44
###begin title 45
The clinical data of the subjects included in the study.
###end title 45
###begin p 46
Values in parentheses for "Dose of each rescue analgesic (mg)" indicate data for dose of each rescue analgesic converted to the equivalent oral morphine dose.
###end p 46
###begin p 47
###xml 443 447 443 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007060-Cohen1">[29]</xref>
###xml 574 579 574 579 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNJ6</italic>
###xml 736 737 736 737 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 737 742 737 742 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2,117</sub>
###xml 752 753 752 753 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 809 810 809 810 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 810 815 810 815 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2,117</sub>
###xml 825 826 825 826 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 866 871 866 871 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNJ6</italic>
###xml 945 946 945 946 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 946 951 946 951 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2,120</sub>
###xml 961 962 961 962 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 973 981 973 981 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Post hoc</italic>
###xml 1059 1060 1059 1060 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1109 1110 1109 1110 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1279 1288 1279 1288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007060-g002">Figure 2A</xref>
###xml 1305 1310 1305 1310 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNJ6</italic>
###xml 1391 1392 1391 1392 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 1392 1397 1392 1397 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2,120</sub>
###xml 1407 1408 1407 1408 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1461 1466 1461 1466 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNJ6</italic>
###xml 1567 1568 1567 1568 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 1568 1572 1568 1572 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2,49</sub>
###xml 1582 1583 1582 1583 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1662 1663 1662 1663 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1735 1736 1735 1736 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1753 1761 1753 1761 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">post hoc</italic>
###xml 1772 1781 1772 1781 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007060-g002">Figure 2B</xref>
###xml 1845 1846 1845 1846 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 1846 1850 1846 1850 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2,68</sub>
###xml 1860 1861 1860 1861 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 2065 2066 2065 2066 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 2066 2070 2066 2070 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2,94</sub>
###xml 2080 2081 2080 2081 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 2099 2100 2099 2100 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 2100 2104 2100 2104 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2,96</sub>
###xml 2114 2115 2114 2115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 2254 2255 2254 2255 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 2265 2266 2265 2266 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 2354 2355 2354 2355 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 2365 2366 2365 2366 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 2397 2405 <span type="species:ncbi:9606">patients</span>
Two-way ANCOVA was performed to examine the effects of SNPs and gender on the frequency of rescue analgesic administration, the total dose of rescue analgesics administered, and NRS pain scores, incorporating the age, height, and weight of the subjects as covariables. Statistical power analyses for the ANCOVA revealed that the expected power (1 minus type II error probability) was 71% for the Cohen's conventional "medium" effect size 0.25 [29] when the sample size was 129 and type I error probability was set at 0.05. Significant associations were not observed between KCNJ6 G-1250A and the frequency of rescue analgesic administration or total dose of rescue analgesics administered (frequency of rescue analgesic administration: F2,117 = 1.145, P = 0.322; total dose of rescue analgesics administered: F2,117 = 1.233, P = 0.295). A significant main effect of KCNJ6 A1032G on the frequency of rescue analgesic administration was observed (F2,120 = 5.336, P = 0.006). Post hoc analysis revealed significant differences between the A/A and A/G genotypes (P = 0.005) and between the A/A and G/G genotypes (P = 0.010), indicating that the carriers of the A/A genotype in the A1032G SNP required rescue analgesics more often compared with carriers of the A/G and G/G genotypes (Figure 2A). The effect of KCNJ6 A1032G on the total dose of rescue analgesics administered was not significant (F2,120 = 1.332, P = 0.268). However, a significant main effect of the KCNJ6 A1032G SNP on the total dose of rescue analgesics administered was observed in the female subjects (F2,49 = 3.428, P = 0.040), and differences were significant between the A/A and A/G genotypes (P = 0.040) and marginally significant between the A/A and G/G genotypes (P = 0.061) in the post hoc analysis (Figure 2B), whereas such differences were not observed in male subjects (F2,68 = 0.032, P = 0.969). Neither the main effect of gender nor the SNPxgender interaction was significant (data not shown). Significant associations were not observed between the two SNPs and NRS pain scores (G-1250A: F2,94 = 1.455, P = 0.239; A1032G: F2,96 = 0.115, P = 0.892), although significant positive correlations were found between NRS pain scores and frequency of rescue analgesic administration (r = 0.281, P = 0.004) and between NRS pain scores and total dose of rescue analgesics administered (r = 0.266, P = 0.006), indicating that the patients who received analgesics more frequently felt more pain, possibly attributable to insufficient analgesic effects.
###end p 47
###begin title 48
Association analysis between requirements for rescue analgesics and SNPs.
###end title 48
###begin p 49
###xml 178 183 178 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNJ6</italic>
The results for the frequency of analgesic administration (A) and the total dose of analgesics administered per weight (B) during the 24 h postoperative period are shown for the KCNJ6 A1032G SNP. The white, striped, and filled boxes indicate results for male, female, and all subjects, respectively. (A) *: significantly more frequent administration for the A/A genotype compared with the A/G and G/G genotypes in all subjects, dagger: significantly more frequent administration for the A/A genotype compared with the A/G and G/G genotypes in female subjects. (B) dagger: significantly greater dose of analgesic administration for the A/A genotype compared with the A/G genotype in female subjects.
###end p 49
###begin p 50
###xml 50 55 50 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNJ6</italic>
###xml 146 154 146 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007060-t006">Table 6A</xref>
###xml 316 317 316 317 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 315 317 315 317 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R<sup>2</sup></italic>
###xml 336 337 336 337 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 419 424 419 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNJ6</italic>
###xml 529 530 529 530 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 528 530 528 530 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R<sup>2</sup></italic>
###xml 540 541 540 541 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 552 553 552 553 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 551 553 551 553 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R<sup>2</sup></italic>
###xml 563 564 563 564 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 716 717 716 717 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 715 717 715 717 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R<sup>2</sup></italic>
###xml 736 737 736 737 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 747 755 747 755 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007060-t006">Table 6B</xref>
###xml 297 304 <span type="species:ncbi:9606">patient</span>
###xml 492 499 <span type="species:ncbi:9606">patient</span>
To examine in more detail the association between KCNJ6 SNPs and rescue analgesic requirements, a haplotype-based test was performed. As shown in Table 6A, a significant association was found between the -1250G/1032A haplotype and the increased frequency of rescue analgesic administration in all patient subjects (R2 = 0.120, adjusted P = 0.015). Although no significant associations were observed between each of the KCNJ6 haplotypes and total dose of rescue analgesics administered in all patient subjects and male subjects (R2 = 0.080, P = 0.328; R2 = 0.028, P = 0.765, respectively), the -1250G/1032A haplotype was significantly associated with total dose of rescue analgesics administered in female subjects (R2 = 0.277, adjusted P = 0.038; Table 6B). Associations between each of the G-1250A/A1032G haplotypes and NRS pain scores were not significant (data not shown).
###end p 50
###begin title 51
###xml 15 20 15 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNJ6</italic>
Association of KCNJ6 haplotypes with postoperative analgesia.
###end title 51
###begin p 52
###xml 317 318 317 318 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 353 354 353 354 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 366 367 366 367 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 375 376 375 376 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 385 386 385 386 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
###xml 384 386 384 386 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P<sup>a</sup></italic>
###xml 397 398 397 398 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 427 433 427 428 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8224;</sup>
###xml 433 434 428 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 441 442 436 437 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*</sup>
###xml 443 444 438 439 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
###xml 442 444 437 439 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P<sup>a</sup></italic>
###xml 123 130 <span type="species:ncbi:9606">patient</span>
###xml 236 243 <span type="species:ncbi:9606">patient</span>
Association of the haplotype composed of the G-1250A/A1032G SNPs with (A) the frequency of analgesic administration in all patient subjects or (B) the total dose of analgesics administered during the 24 h postoperative period in female patient subjects. Frequency, haplotype frequency; Beta, regression coefficient; R2, coefficient of determination; F, F statistic; P, crude P value; Pa, adjusted P value for multiple testing. daggerP<0.05, *Pa<0.05.
###end p 52
###begin p 53
###xml 30 35 30 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNJ6</italic>
###xml 95 100 95 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNJ6</italic>
###xml 368 376 360 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007060-g003">Figure 3</xref>
###xml 590 591 582 583 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 591 593 583 585 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">98</sub>
###xml 603 604 595 596 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
To estimate the impact of the KCNJ6 A1032G polymorphism on gene expression level, the relative KCNJ6 mRNA expression level was compared between the genotype subgroups of the SMRI samples in the real-time qPCR. The relative expression level (mean+/-SEM) was 1.59+/-0.17, 2.07+/-0.08, and 1.99+/-0.06 for the A/A, A/G, and G/G genotypes in the A1032G SNP, respectively (Figure 3), demonstrating that the expression level was 0.76-0.80 fold lower in the A/A genotype than in the A/G and G/G genotype. The difference was significant between the A/A genotype and combined A/G and G/G genotypes (t98 = 2.265, P = 0.026).
###end p 53
###begin title 54
###xml 9 14 9 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNJ6</italic>
Relative KCNJ6 mRNA expression level between each genotype subgroup of the SMRI samples.
###end title 54
###begin p 55
*: significantly lower expression level between the A/A genotype and combined A/G and G/G genotypes in all subjects.
###end p 55
###begin title 56
Discussion
###end title 56
###begin p 57
###xml 43 48 43 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNJ6</italic>
###xml 247 252 247 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNJ6</italic>
###xml 677 692 677 692 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007060-g002">Figure 2A and B</xref>
###xml 694 701 694 701 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007060-t006">Table 6</xref>
###xml 871 872 871 872 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 902 907 902 907 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNJ6</italic>
###xml 1434 1439 1434 1439 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNJ6</italic>
###xml 1695 1700 1695 1700 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNJ6</italic>
###xml 71 77 <span type="species:ncbi:9606">humans</span>
###xml 349 355 <span type="species:ncbi:9606">humans</span>
###xml 1171 1179 <span type="species:ncbi:9606">Patients</span>
###xml 1595 1600 <span type="species:ncbi:9606">human</span>
The present study comprehensively examined KCNJ6 genetic variations in humans and explored the associations between these variations and outcomes in clinical pain management. To our knowledge, the present study is the first to explore SNPs of the KCNJ6 gene with regard to associations between these SNPs and postoperative analgesic requirements in humans. We found that carriers of the A/A genotype in the A1032G SNP or -1250G/1032A haplotype required rescue analgesics more often and tended to require higher doses of rescue analgesics, especially in female subjects, compared with carriers of other genotypes or haplotypes, respectively, after major open abdominal surgery (Figure 2A and B, Table 6). Although we did not show all of the results of multiple testing for the G-1250A and A1032G SNPs with the Bonferroni correction because this study was explorative, the P value for the main effect of KCNJ6 A1032G on the frequency of rescue analgesic administration was 0.012 after the Bonferroni correction. This suggests that this SNP is likely to affect sensitivity to analgesics, although we must concede that this significance might possibly occur by chance alone. Patients who experienced more severe pain, evaluated by NRS pain scores, required higher-dose and more frequent rescue analgesics, although significant associations were not observed between the A1032G SNP or -1250G/1032A haplotype and NRS pain scores. Moreover, KCNJ6 gene expression levels in the 1032A/A subjects was significantly decreased compared with 1032A/G and 1032G/G subjects in the real-time qPCR analysis using human brain tissues, suggesting that the 1032A/A subjects required more analgesics because of lower KCNJ6 gene expression levels and consequently insufficient analgesic effects. Altogether, these results suggest that subjects carrying the A/A genotype in the A1032G SNP or -1250G/1032A haplotype, especially in females, had lower sensitivity to analgesics and, therefore, required more rescue analgesics than subjects carrying other genotypes or haplotypes to achieve a similar degree of pain relief.
###end p 57
###begin p 58
###xml 452 453 452 453 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 451 453 451 453 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R<sup>2</sup></italic>
For our ANCOVA analyses, the desirable sample size was calculated as 158 for the effect size 0.25 to achieve 80% power. This might suggest that a sample size of 129 subjects in our study was somewhat insufficient to reliably detect moderate differences between the SNP genotypes, and a far greater sample may be required to detect smaller differences. Considering this caveat and relatively small effect size observed in the haplotype analysis (e.g., R2 for haplotype effect on the frequency of analgesic administration was 0.120), future studies with larger sample sizes may reveal additional associations between polymorphisms and opioid sensitivity.
###end p 58
###begin p 59
###xml 42 47 42 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNJ6</italic>
###xml 152 160 152 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007060-g001">Figure 1</xref>
###xml 343 348 343 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNJ6</italic>
###xml 513 519 513 519 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">weaver</italic>
###xml 599 604 599 604 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kcnj6</italic>
###xml 670 674 670 674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007060-Rakic1">[30]</xref>
###xml 698 702 698 702 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007060-Patil1">[31]</xref>
###xml 713 714 713 714 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 727 731 727 731 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007060-Navarro1">[32]</xref>
###xml 733 737 733 737 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007060-Tong1">[33]</xref>
###xml 797 800 797 800 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007060-Ikeda2">[3]</xref>
###xml 844 848 844 848 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007060-Kobayashi3">[34]</xref>
###xml 854 859 854 859 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kcnj6</italic>
###xml 337 342 <span type="species:ncbi:9606">human</span>
###xml 520 524 <span type="species:ncbi:10090">mice</span>
###xml 593 598 <span type="species:ncbi:10090">mouse</span>
###xml 792 796 <span type="species:ncbi:10090">mice</span>
###xml 958 963 <span type="species:ncbi:9606">human</span>
###xml 968 973 <span type="species:ncbi:10090">mouse</span>
In the initial polymorphism screening for KCNJ6, a total of nine SNPs were identified in the whole exon, 5'-flanking, and exon-intron boundary regions (Figure 1). Polymorphisms that might cause significant functional changes, such as nonsynonymous or insertion/deletion polymorphisms, were not found in the polymorphism screening of the human KCNJ6 gene in the present study, possibly attributable to the importance and high conservation of mammalian GIRK channels. A possible explanation derives from studies in weaver mice, in which only a single missense mutation in the pore region of the mouse Kcnj6 gene causes various aberrant changes in cerebellar granule cells [30], membrane permeability [31], loss of K+ selectivity [32], [33], significantly lower analgesia compared with wildtype mice [3], and lack of activating effects of ethanol [34]. The Kcnj6 gene orthologs might be under purifying selection over many generations of the species, including human and mouse, because of the profound functional constraints attributable to the importance of these orthologs in these organisms.
###end p 59
###begin p 60
###xml 574 579 574 579 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNJ6</italic>
###xml 606 615 606 615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007060.s002">Figure S1</xref>
###xml 1018 1022 1018 1022 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007060-Yan1">[35]</xref>
###xml 1105 1109 1105 1109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007060-Zhang1">[36]</xref>
###xml 1169 1173 1169 1173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007060-Duan1">[37]</xref>
###xml 1275 1279 1275 1279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007060-KimchiSarfaty1">[38]</xref>
The A/A genotype in the A1032G SNP was significantly associated with increased postoperative analgesic requirements in our study. The G allele appears to be dominant in mediating the transmission of intensified opioid signaling compared with the A allele. However, this particular SNP is synonymous and causes no amino acid change; therefore, the protein structure encoded by this gene may not be altered by this SNP. Nevertheless, local structural difference in the 1023-1059 position was observed between the sequences, including 1032A and 1032G, in our prediction of the KCNJ6 mRNA secondary structure (Figure S1). Whereas the 1032A mRNA formed an interior loop, a hairpin loop, and a 6 bp helix, the 1032G mRNA formed a bulge loop as well as an interior loop, a hairpin loop, and a 7 bp helix in the local structure. Although the role of this difference in gene function remains to be determined, the SNP may actually influence mRNA expression level. Indeed, recent studies measuring allelic expression imbalances [35] have demonstrated that even a synonymous SNP could affect mRNA and protein levels [36], possibly by altering mRNA stability and protein synthesis [37]. Similar mRNA and protein levels, but altered conformations, were found for synonymous polymorphisms [38].
###end p 60
###begin p 61
###xml 163 168 163 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNJ6</italic>
###xml 671 676 671 676 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNJ6</italic>
To further infer the precise mechanism underlying the increased requirements for rescue analgesics in the A/A subjects in the A1032G SNP, we compared the relative KCNJ6 mRNA expression level between the genotype subgroups of the SMRI samples in the real-time qPCR. A significant difference in expression level was observed between the A/A genotype and the combined A/G and G/G genotypes, consistent with the results of the association study, in which only the subjects with the A/A genotype in this SNP demonstrated significantly higher requirements for rescue analgesics than the other genotypes. The 1032A/A subjects required more analgesics, probably because of lower KCNJ6 gene expression levels and consequently insufficient analgesic effects.
###end p 61
###begin p 62
We do not have any evidence to explain how the -1250G/1032A haplotype contributes to increased requirements for rescue analgesics compared with other haplotypes. One might infer that the G-1250A SNP in the putative regulatory region could be related to some moderate functional alteration, and the -1250G and 1032A alleles could be risk factors for decreased sensitivity to analgesics. Both alleles might combine synergistically to cause profound decreases in sensitivity to analgesics. Future functional studies focusing on both the G-1250A and A1032G SNPs are required to investigate this hypothesis.
###end p 62
###begin p 63
###xml 39 44 39 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNJ6</italic>
###xml 200 205 200 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNJ6</italic>
In conclusion, the A/A genotype in the KCNJ6 A1032G SNP and -1250G/1032A haplotype were significantly associated with increased analgesic requirements after major open abdominal surgery. Furthermore, KCNJ6 gene expression levels in the 1032A/A subjects was significantly decreased compared with the 1032A/G and 1032G/G subjects. Although the association might be restricted to the Japanese population, and the mechanism by which individual sensitivity to postoperative analgesics is altered by the G-1250A and A1032G SNPs remains to be fully elucidated, the outcome indicates that the A1032G SNP and G-1250A/A1032G haplotype could serve as markers that predict increased analgesic requirements. Our findings will provide valuable information to better modulate individual analgesic dosages required to achieve satisfactory pain control and open new avenues for personalized pain treatment.
###end p 63
###begin title 64
Supporting Information
###end title 64
###begin p 65
The clinical data of the subjects stratified by genotype
###end p 65
###begin p 66
(0.12 MB DOC)
###end p 66
###begin p 67
Click here for additional data file.
###end p 67
###begin p 68
###xml 158 163 158 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNJ6</italic>
Predicted secondary structure for the KCNJ6 mRNA based on the nucleotide sequences of the GenBank database (accession number: NM_002240.2). The sequences for KCNJ6 mRNA position 1012-1072 are presented for the 1032A (A) and 1032G (B) mRNA. The numbers next to the sequences indicate relative positions from position 982.
###end p 68
###begin p 69
(0.99 MB TIF)
###end p 69
###begin p 70
Click here for additional data file.
###end p 70
###begin p 71
We acknowledge Mr. Michael Arends for his assistance with editing the manuscript. We are grateful to the volunteers for their participation in this study and the anesthesiologists and surgeons at Research Hospital, Institute of Medical Science, The University of Tokyo, and Toho University Sakura Medical Center for collecting clinical data. We thank the Stanley Medical Research Institute for providing SMRI samples.
###end p 71
###begin title 72
References
###end title 72
###begin article-title 73
How individual sensitivity to opiates can be predicted by gene analyses.
###end article-title 73
###begin article-title 74
Environmental and genetic factors associated with morphine response in the postoperative period.
###end article-title 74
###begin article-title 75
Molecular mechanisms of analgesia induced by opioids and ethanol: is the GIRK channel one of the keys?
###end article-title 75
###begin article-title 76
###xml 62 67 62 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kcnj9</italic>
Quantitative trait locus and computational mapping identifies Kcnj9 (GIRK3) as a candidate gene affecting analgesia from multiple drug classes.
###end article-title 76
###begin article-title 77
G protein-activated inwardly rectifying potassium channels as potential therapeutic targets.
###end article-title 77
###begin article-title 78
Spinal G-protein-gated potassium channels contribute in a dose-dependent manner to the analgesic effect of mu- and delta- but not kappa-opioids.
###end article-title 78
###begin article-title 79
Spinal G-protein-gated potassium channels contribute in a dose-dependent manner to the analgesic effect of mu- and delta- but not kappa-opioids.
###end article-title 79
###begin article-title 80
###xml 24 25 24 25 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
Spinal G-protein-gated K+ channels formed by GIRK1 and GIRK2 subunits modulate thermal nociception and contribute to morphine analgesia.
###end article-title 80
###begin article-title 81
###xml 77 78 77 78 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
Functional and biochemical evidence for G-protein-gated inwardly rectifying K+ (GIRK) channels composed of GIRK2 and GIRK3.
###end article-title 81
###begin article-title 82
###xml 50 51 50 51 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 23 28 <span type="species:ncbi:10090">mouse</span>
###xml 136 141 <span type="species:ncbi:10090">mouse</span>
Molecular cloning of a mouse G-protein-activated K+ channel (mGIRK1) and distinct distributions of three GIRK (GIRK1, 2 and 3) mRNAs in mouse brain.
###end article-title 82
###begin article-title 83
###xml 65 66 65 66 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
Brain localization and behavioral impact of the G-protein-gated K+ channel subunit GIRK4.
###end article-title 83
###begin article-title 84
###xml 56 57 56 57 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
Involvement of G-protein-activated inwardly rectifying K+ (GIRK) channels in opioid-induced analgesia.
###end article-title 84
###begin article-title 85
A pervasive mechanism for analgesia: activation of GIRK2 channels.
###end article-title 85
###begin article-title 86
###xml 98 102 <span type="species:ncbi:10090">mice</span>
Hyperalgesia and blunted morphine analgesia in G protein-gated potassium channel subunit knockout mice.
###end article-title 86
###begin article-title 87
###xml 73 74 69 70 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Contribution of GIRK2-mediated postsynaptic signaling to opiate and alpha2-adrenergic analgesia and analgesic sex differences.
###end article-title 87
###begin article-title 88
###xml 36 41 <span type="species:ncbi:9606">human</span>
Characterization and variation of a human inwardly-rectifying-K-channel gene (KCNJ6): a putative ATP-sensitive K-channel subunit.
###end article-title 88
###begin article-title 89
###xml 76 81 76 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNJ3</italic>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human G-protein-coupled inwardly rectifying potassium channel (GIRK1) gene (KCNJ3): localization to chromosome 2 and identification of a simple tandem repeat polymorphism.
###end article-title 89
###begin article-title 90
###xml 131 139 <span type="species:ncbi:9606">patients</span>
No evidence for mutations in a putative subunit of the beta-cell ATP-sensitive potassium channel (K-ATP channel) in Japanese NIDDM patients.
###end article-title 90
###begin article-title 91
###xml 73 78 73 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPRM1</italic>
Analgesic requirements after major abdominal surgery are associated with OPRM1 gene polymorphism genotype and haplotype.
###end article-title 91
###begin article-title 92
###xml 106 112 <span type="species:ncbi:9606">humans</span>
Additional SNPs and linkage-disequilibrium analyses are necessary for whole-genome association studies in humans.
###end article-title 92
###begin article-title 93
Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium.
###end article-title 93
###begin article-title 94
Efficiency and power in genetic association studies.
###end article-title 94
###begin article-title 95
Haploview: analysis and visualization of LD and haplotype maps.
###end article-title 95
###begin article-title 96
###xml 41 46 <span type="species:ncbi:9606">human</span>
The structure of haplotype blocks in the human genome.
###end article-title 96
###begin article-title 97
Mfold web server for nucleic acid folding and hybridization prediction.
###end article-title 97
###begin article-title 98
G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences.
###end article-title 98
###begin article-title 99
PLINK: a tool set for whole-genome association and population-based linkage analyses.
###end article-title 99
###begin article-title 100
Controlling the false discovery rate: a practical and powerful approach to multiple testing.
###end article-title 100
###begin article-title 101
Statistical power analysis for the behavioral sciences (revised edition).
###end article-title 101
###begin article-title 102
###xml 14 19 <span type="species:ncbi:10090">mouse</span>
Weaver mutant mouse cerebellum: defective neuronal migration secondary to abnormality of Bergmann glia.
###end article-title 102
###begin article-title 103
###xml 39 43 <span type="species:ncbi:10090">mice</span>
A potassium channel mutation in weaver mice implicates membrane excitability in granule cell differentiation.
###end article-title 103
###begin article-title 104
###xml 48 49 41 42 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
Nonselective and Gbetagamma-insensitive weaver K+ channels.
###end article-title 104
###begin article-title 105
The weaver mutation changes the ion selectivity of the affected inwardly rectifying potassium channel GIRK2.
###end article-title 105
###begin article-title 106
###xml 55 56 55 56 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
Ethanol opens G-protein-activated inwardly rectifying K+ channels.
###end article-title 106
###begin article-title 107
###xml 21 26 <span type="species:ncbi:9606">human</span>
Allelic variation in human gene expression.
###end article-title 107
###begin article-title 108
###xml 83 88 83 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A118G</italic>
###xml 32 37 <span type="species:ncbi:9606">human</span>
Allelic expression imbalance of human mu opioid receptor (OPRM1) caused by variant A118G.
###end article-title 108
###begin article-title 109
###xml 28 33 <span type="species:ncbi:9606">human</span>
Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor.
###end article-title 109
###begin article-title 110
###xml 31 35 31 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDR1</italic>
A "silent" polymorphism in the MDR1 gene changes substrate specificity.
###end article-title 110
###begin article-title 111
Morphine and oxycodone hydrochloride in the management of cancer pain.
###end article-title 111
###begin article-title 112
Epidural morphine in the elderly: a controlled trial after upper abdominal surgery.
###end article-title 112
###begin article-title 113
Opioid agonist-antagonist drugs in acute and chronic pain states.
###end article-title 113
###begin article-title 114
Self-administered nalbuphine, morphine and pethidine: comparison, by intravenous route, following cholecystectomy.
###end article-title 114
###begin article-title 115
Continuous opioid infusion for scoliosis fusion surgery.
###end article-title 115
###begin article-title 116
Four analgesic techniques for shockwave lithotripsy: eutectic mixture local anesthetic is a good alternative.
###end article-title 116
###begin article-title 117
Comparison of three analgesics for extracorporeal shock wave lithotripsy.
###end article-title 117
###begin article-title 118
European experience with flurbiprofen: a new analgesic/anti-inflammatory agent.
###end article-title 118
###begin article-title 119
Nonnarcotic analgesics.
###end article-title 119
###begin p 120
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 120
###begin p 121
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by grants from the Ministry of Health, Labour and Welfare of Japan (H17-Pharmaco-001, H19-Iyaku-023), the Ministry of Education, Culture, Sports, Science and Technology of Japan (20602020, 19659405, 20390162), The Naito Foundation, and The Mitsubishi Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 121

